Andere talen Huons Co., Ltd.

Aandelen

A243070

KR7243070000

slotkoers Korea S.E. Andere beurzen 00:00:00 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
34.950 ^KRW	+0,58%		+1,75%	-8,98%

20/03	Huons Co., Ltd. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2023	CI
2023	Huons Co. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2022	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

PanGen Biotech Inc. announced that it has received KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.	27/03
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
PanGen Biotech Inc. announced that it expects to receive KRW 3.999986631 billion in funding from CrystalGenomics Invites Co., LTD., Huons Co., Ltd., Hwail Pharmaceutical Co.,Ltd.	18/03
GenEdit Inc. announced that it has received $24 million in funding from Korea Innovative Medicines Consortium, Dong-A ST Co., Ltd., Huons Co., Ltd.	24/01
Huons Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23
South Korea's Huons to Export Anesthetics to Canada	01-03-23
GenEdit Inc. amended terms of the transaction	28-02-23
South Korean Stocks Turn Upbeat as China COVID-19 Lockdown Restrictions Ease; Huons Adds 1%	29-11-22
Huons to Invest $18.3 Million to Raise Production Capacity for Injectable Products at Jecheon Plant	29-11-22
GenEdit Inc. announced that it expects to receive $30 million in funding	09-11-22
Haemato : to Seek EU Approval for Botox Product	25-10-21
PanGen Biotech Inc. announced that it has received KRW 9.99998571 billion in funding from Huons Co., Ltd. and another investor	11-06-21
PanGen Biotech Inc. announced that it expects to receive KRW 9.99998571 billion in funding from Huons Co., Ltd., and another investor	03-06-21
Pharmcadd Co, Ltd announced that it has received $16 million in funding from a group of investors	19-04-21
Master Meditech Inc. announced that it has received KRW 8 billion in funding from Samho Green Investment, Inc., Paratus Investment Inc., Spring Camp, Huons Co., Ltd., Pharmbio Co., Ltd., INNOCENCE Co.Ltd	29-03-21
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.	23-02-21
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.	23-02-21
Huons Co., Ltd.'s Equity Buyback announced on August 14, 2020, has expired with 80,102 shares, representing 0.74% for KRW 4,989.56 million.	18-02-21
LIPAC Oncology Announces Major Partnering Milestone Achieved in Its License Agreement with Huons Co., Ltd	10-12-20
Tranche Update on Huons Co., Ltd.'s Equity Buyback Plan announced on August 14, 2020.	23-11-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Huons Co., Ltd.

Aandelen

A243070

KR7243070000

Andere talen

Filters